Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Jan 1;35(1):36-41.
doi: 10.1097/PEP.0000000000000968. Epub 2022 Oct 25.

Scoring People With Spinal Muscular Atrophy on the Motor Function Measure Using the Microsoft Kinect

Affiliations
Multicenter Study

Scoring People With Spinal Muscular Atrophy on the Motor Function Measure Using the Microsoft Kinect

Dominique Vincent-Genod et al. Pediatr Phys Ther. .

Abstract

Purpose: Assess the ability of the Kinect to capture movement and posture of people with spinal muscular atrophy (SMA) during completion of 14 items of the Motor Function Measure, a validated functional rating scale for people with neuromuscular diseases.

Methods: Multicenter feasibility study in which Motor Function Measure items were scored as usual by the participant's therapist during the completion (Score-T) while another therapist scored items based only on the visualization of digital data collected using the Kinect (Score-D). Agreement and disagreement were investigated.

Results: Twenty people with SMA type 2 or 3 were participants; 142 items were recorded and analyzed. There was 31.7% agreement between Score-T and Score-D for participants with SMA type 2, and 76.2% for those with SMA type 3.

Conclusions: The results prevent us from considering the use of Kinect capture to deduce an automated scoring, but this device may be of interest to highlight potential compensations.

Trial registration: ClinicalTrials.gov NCT02628743.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Verhaart IEC, Robertson A, Leary R, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264(7):1465–1473. doi:10.1007/s00415-017-8549-1.
    1. Munsat TL, Davies KE. International SMA consortium meeting (26-28 June 1992, Bonn, Germany). Neuromuscul Disord. 1992;2(5):423–428. doi:10.1016/S0960-8966(06)80015-5.
    1. Lunn MR, Wang CH. Spinal muscular atrophy. Lancet. 2008;371(9630):2120–2133. doi:10.1016/S0140-6736(08)60921-6.
    1. Finkel R, Bertini E, Muntoni F, Mercuri E; ENMC SMA Workshop Study Group. 209th ENMC International Workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7-9 November 2014, Heemskerk, The Netherlands. Neuromuscul Disord. 2015;25(7):593–602. doi:10.1016/j.nmd.2015.04.009.
    1. Messina S, Sframeli M. New treatments in spinal muscular atrophy: positive results and new challenges. J Clin Med. 2020;9(7):2222. doi:10.3390/jcm9072222.

Publication types

Associated data